Literature DB >> 8983691

Hypereosinophilic syndrome: endomyocardial fibrosis.

M Pitt1, M K Davies, A J Brady.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8983691      PMCID: PMC484556          DOI: 10.1136/hrt.76.4.377

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  2 in total

Review 1.  Relation between eosinophilia and endomyocardial disease.

Authors:  E G Olsen; C J Spry
Journal:  Prog Cardiovasc Dis       Date:  1985 Jan-Feb       Impact factor: 8.194

2.  Pulmonary fibrosis associated with nabumetone.

Authors:  A Morice; A Atherton; F Gleeson; S Stewart
Journal:  Postgrad Med J       Date:  1991-11       Impact factor: 2.401

  2 in total
  5 in total

1.  Rapid left ventricular thickening and thrombus caused by FIP1L1/PDGFRA-negative hypereosinophilic syndrome.

Authors:  Ho-Young Yhim; Sang-Rok Lee
Journal:  Tex Heart Inst J       Date:  2013

2.  Endomyocardial fibrosis in Egypt: an illustrated review.

Authors:  J H Antonio; M C Diniz; D Miranda; H L Soares; E J Melo; D Miranda; A Nunes
Journal:  Heart       Date:  1997-04       Impact factor: 5.994

3.  Hypereosinophilic syndrome: endomyocardial fibrosis.

Authors:  J Mayet; P Kanagaratnam; C Lincoln; P Oldershaw
Journal:  Heart       Date:  1997-04       Impact factor: 5.994

4.  Control of hypereosinophilic syndrome-associated recalcitrant coronary artery spasm by combined treatment with prednisone, imatinib mesylate and hydroxyurea.

Authors:  Joseph H Butterfield; Scott W Sharkey
Journal:  Exp Clin Cardiol       Date:  2006

5.  Echocardiographic Changes in Eosinophilic Endocarditis Induced by Churg-Strauss Syndrome.

Authors:  Nobuyuki Masaki; Ami Issiki; Masato Kirimura; Tetsuo Kamiyama; Osamu Sasaki; Hiroyuki Ito; Yoshiaki Maruyama; Toshihiko Nishioka
Journal:  Intern Med       Date:  2016-10-01       Impact factor: 1.271

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.